
Acrux ( ($AU:ACR) ) has shared an announcement. Acrux Limited is an ASX-listed company, but the release does not provide details of its industry, products, services, or market focus. The
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| ARUXF | Acrux | 0.01 | 0.00 | 60.00% |
| Name | Price | % Change | |
|---|---|---|---|
| $0.01 | +60.00% |

Acrux ( ($AU:ACR) ) has shared an announcement. Acrux Limited is an ASX-listed company, but the release does not provide details of its industry, products, services, or market focus. The

Acrux ( ($AU:ACR) ) has issued an update. Acrux Limited applied for quotation of 100,000 fully paid ordinary shares on the ASX, with an issue date of November 4, 2026.

Acrux ( ($AU:ACR) ) has provided an update. Acrux Ltd has called its 2026 Annual General Meeting for 24 November in Melbourne, inviting shareholders to attend in person or lodge

An announcement from Acrux ( ($AU:ACR) ) is now available. Acrux Limited, an Australian Securities Exchange-listed pharmaceutical company, issues ordinary fully paid shares under the code ACR as part of

Acrux ( ($AU:ACR) ) has shared an announcement. Acrux reported positive net operating cash of $0.266 million for the September quarter, supported by the receipt of a $1.977 million Research

Acrux ( ($AU:ACR) ) has shared an announcement. Acrux Limited, an Australian pharmaceutical developer of transdermal drug delivery products, is advancing a metered-dose testosterone spray for postmenopausal women with hypoactive

An announcement from Acrux ( ($AU:ACR) ) is now available. Acrux has scheduled a live investor webinar on 12 October 2026 to brief shareholders on its Female Testosterone Metered Dose

The latest announcement is out from Acrux ( ($AU:ACR) ). Acrux Limited has scheduled its next Annual General Meeting for 24 November 2026 at the offices of Pitcher Partners in

Acrux ( ($AU:ACR) ) just unveiled an update. Acrux Limited has applied for quotation on the ASX of 4,109,653 ordinary fully paid shares, with an issue date of 14 September

Acrux ( ($AU:ACR) ) has issued an update. Acrux Limited has reported a change in director Geoffrey Brooke’s interests, reflecting an issue of 2,400,000 new ordinary shares to him supported
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Mar 2, 2027TBA | $3.73M | ― | ― | 0.09 | -6.43 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.